Related references
Note: Only part of the references are listed.The inhibition of cholesteryl ester transfer protein: a long and winding road
Kerry-Anne Rye et al.
JOURNAL OF LIPID RESEARCH (2012)
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Philip J. Barter et al.
JOURNAL OF LIPID RESEARCH (2012)
Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein
Lei Zhang et al.
NATURE CHEMICAL BIOLOGY (2012)
Structural and biophysical insight into cholesteryl ester-transfer protein
Justin Hall et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism
Eric J. Niesor
CURRENT OPINION IN LIPIDOLOGY (2011)
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2010)
Model of human low-density lipoprotein and bound receptor based on CryoEM
Gang Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disruption of Human Plasma High-Density Lipoproteins by Streptococcal Serum Opacity Factor Requires Labile Apolipoprotein A-I
Mikyung Han et al.
BIOCHEMISTRY (2009)
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
Ramachandran S. Vasan et al.
CIRCULATION (2009)
Enhanced cellular uptake of remnant high-density lipoprotein particles - A mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia
Changting Xiao et al.
CIRCULATION RESEARCH (2008)
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein
Patricia A. Thompson et al.
INNATE IMMUNITY (2008)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Partial suppression of CETP activity beneficially modifies the lipid transfer profile of plasma
Richard E. Morton et al.
ATHEROSCLEROSIS (2007)
Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules
Xiayang Qiu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Apolipophorin III: Role model apolipoprotein
PMM Weers et al.
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
The surface cholesteryl ester content of donor and acceptor particles regulates CETP: a liposome-based approach to assess the substrate properties of lipoproteins
RE Morton et al.
JOURNAL OF LIPID RESEARCH (2003)
Human plasma high-density lipoproteins are stabilized by kinetic factors
R Mehta et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL
RE Morton et al.
JOURNAL OF LIPID RESEARCH (2003)
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis et al.
JOURNAL OF LIPID RESEARCH (2002)
Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice
T Gautier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Human apolipoprotein C-I accounts for the ability of plasma nigh density lipoproteins to inhibit the cholesteryl ester transfer protein activity
T Gautier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
